![The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity]()
The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicityAbuhay, Mastewal; Kato, Jason; Tuscano, Emily; Barisone, Gustavo A.; Sidhu, Ranjit S.; O’Donnell, Robert T.; Tuscano, Joseph M. · Cancer Immunology, Immunotherapy · 2016